For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| HAV Treatment | Human Acellular Vessel (HAV) Human Acellular Vessel (HAV): Patients will be implanted with a Human Acellular Vessel (HAV) as a femoro-popliteal bypass conduit using standard vascular surgical techniques | 1 | None | 11 | 15 | 15 | 15 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Impaired healing, Oedema peripheral, Pain, Vascular stent restenosis | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Corona virus infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pleural effusion, Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Arterial insufficiency | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Cardiac failure acute | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Gastrointestinal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Anastomic stenosis, Arterial bypass stenosis, Arterial bypass thrombosis, continued in description | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Hyperglycaemic hyperosmolar nonketotic syndrome | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Adenocarcinoma of colon | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Lymphadenopathy | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Angina pectoris, Coronary artery disease | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Implant site extravasation, Peripheral swelling | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cholecystitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Bronchitis, Diverticulitis, Groin infection, Osteomyelitis, Rhinovirus infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Post procedural swelling, Seroma, Vascular pseudoaneurysm thrombosis, Wound decomposition | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Pulse absent, Scan myocardial perfusion abnormal | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Gout, Hyperuricaemia, Vitamin B12 deficiency | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Arthralgia, Back pain, Muscle necrosis, Musculoskeletal pain, Pain in extremity, Tenosynovitis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Dizziness, Headache, Neuralgia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Anxiety, Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Renal cyst | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Cough, Pleural effusion, Pulmonary mass | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Dermatitis, Skin hyperpigmentation, Skin ulcer | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Arterial stenosis, Haematoma, Intermittent claudication, Continued in description | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |